Calendar Tilray Brands, Inc.

Equities

TLRY

US88688T1007

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 03:44:06 2024-12-09 pm EST			5-day change	1st Jan Change
1.305 ^USD	+1.95%		-2.24%	-43.04%

Nov. 14	Tilray Brief: Tilray Medical Launching its First Commercial "Grown in Germany" Medical Cannabis Products Under its Newly Expanded Cultivation License	MT
Nov. 07	Global markets live: Qualcomm, ARM, Lyft, AppLovin, AstraZeneca...

Chart calendar Tilray Brands, Inc.

26e3cf1e9.SNbJzvJLjWM_hOUH6WD-YgrrvW3bWmnDVefwWIhgNoU.JJiBn7oA3BVd3YZt3AWRLjrY617vLFH3JK6xDbw2WugK4p-soSzGU0nVsA~b983aecc359a3bb552d44e74e8c03064

Upcoming events on Tilray Brands, Inc.

2025-01-12	Q2 2025 Earnings Release (Projected)
2025-04-14	Q3 2025 Earnings Release (Projected)
2025-07-22	Q4 2025 Earnings Release (Projected)
2025-10-01	Q1 2026 Earnings Release (Projected)

Past events on Tilray Brands, Inc.

2024-10-10 08:30 am	Q1 2025 Earnings Call
2024-10-10 07:00 am	Q1 2025 Earnings Release
2024-08-14 10:30 am	CG Growth Conference
2024-07-29 04:30 pm	Q4 2024 Earnings Call
2024-07-29 04:05 pm	Q4 2024 Earnings Release
2024-04-09 08:30 am	Q3 2024 Earnings Call
2024-04-09 07:00 am	Q3 2024 Earnings Release
2024-01-09 08:30 am	Q2 2024 Earnings Call
2024-01-09 07:00 am	Q2 2024 Earnings Release
2023-11-21 11:00 am	Annual General Meeting
2023-10-04 08:30 am	Q1 2024 Earnings Call
2023-10-04 07:00 am	Q1 2024 Earnings Release
2023-08-07 04:45 pm	Acquisition of Eight Beer and Beverage Brands From Anheuser-Busch by Tilray Brands Inc Call
2023-07-26 08:30 am	Q4 2023 Earnings Call
2023-07-26 07:00 am	Q4 2023 Earnings Release
2023-04-10 05:00 pm	Q3 2023 Earnings Call
2023-04-10 07:00 am	Q3 2023 Earnings Release
2023-03-16 11:00 am	Annual General Meeting - adjourned
2023-01-09 08:30 am	Interim 2023 Earnings Call
2023-01-09 07:00 am	Interim 2023 Earnings Release

Annual results

Fiscal Period	Maggio	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	628 630 -0.23%	627 598 4.8%	789 783 0.74%	904	958	1 041
EBITDA Million USD	Released Forecast Spread	48,0 46,8 2.59%	61,5 59,3 3.76%	60,5 59,7 1.23%	68,8	87,8	120
EBIT Million USD	Released Forecast Spread	-143 -175 18.52%	-108 -126 14.27%	-175 -171 -2.01%	-85,6	-63,0	0,00
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-441 -20,7 -2025.84%	-1 450 -1 071 -35.36%	-249 -210 -18.48%	-72,3	-68,2	33,4
Net income Million USD	Released Forecast Spread	-434 -42,0 -933.57%	-1 443 -1 212 -19.1%	-222 -217 -2.28%	-89,2	-75,3	-8,89
EPS USD	Released Forecast Spread	-0,90 -0,04 -1993.02%	-2,35 -2,01 -17.09%	-0,33 -0,32 -2.21%	-0,10	-0,09	-0,01
Announcement Date		28/07/22	26/07/23	29/07/24	-

Quarterly results

Fiscal Period	Agosto	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	146 150 -3.02%	184 154 19.63%	177 174 1.54%	194 195 -0.64%	188 198 -5.04%	230 227 1.14%	200 221 -9.42%	218	220	268	230	234	232	275
EBITDA Million USD	Released Forecast Spread	14,0 16,9 -17.17%	22,2 19,9 11.75%	11,4 11,2 1.85%	10,1 13,6 -25.58%	10,2 13,7 -25.74%	29,5 28,5 3.53%	9,33 13,4 -30.47%	12,4	13,0	34,5	18,4	19,4	19,2	31,9
EBIT Million USD	Released Forecast Spread	-29,4 -23,6 -24.67%	-16,6 -22,7 27.01%	-34,4 -27,7 -23.88%	-41,8 -26,6 -57.22%	-82,1 -28,6 -186.92%	-16,5 -12,7 -30.38%	-36,6 -18,5 -97.85%	-22,5	-24,0	-0,73	-20,2	-17,7	-19,9	0,90
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-1 207 -32,5 -3612.66%	-112 -28,8 -287.22%	-48,6 -36,0 -35.17%	-49,6 -39,1 -26.83%	-108 -37,7 -185.88%	-43,0 -21,3 -101.9%	-33,8 -30,0 -12.58%	-36,7	-35,4	-17,5
Net income Million USD	Released Forecast Spread	-1 196 -29,8 -3906.27%	-120 -27,8 -331.66%	-55,9 -34,4 -62.61%	-46,2 -38,5 -19.82%	-105 -38,4 -173.47%	-15,4 -20,4 24.71%	-34,7 -28,6 -21.34%	-35,1	-33,8	-15,4
EPS USD	Released Forecast Spread	-1,90 -0,05 -3594.34%	-0,15 -0,04 -259.97%	-0,10 -0,05 -93.54%	-0,07 -0,06 -23.52%	-0,12 -0,05 -127.01%	-0,04 -0,02 -71.45%	-0,04 -0,05 20%	-0,04	-0,04	-0,02
Announcement Date		10/04/23	26/07/23	04/10/23	09/01/24	09/04/24	29/07/24	10/10/24	-	-	-	-	-	-	-

Upcoming sector events for Tilray Brands, Inc.

2024-12-10 11:45 am	MEDINCELL S.A.: Q2 2025 Earnings Release
2025-01-08	HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release
2025-01-12	TILRAY BRANDS, INC.: Q2 2025 Earnings Release (Projected)
2025-01-20	AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	AARTI DRUGS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	ALEMBIC PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	JOHNSON & JOHNSON: Q4 2024 Earnings Release
2025-01-22	GLENMARK LIFE SCIENCES LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-27	GRANULES INDIA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-28	MANKIND PHARMA LIMITED: Q3 2025 Earnings Release (Projected)

More events

Past sector events for Tilray Brands, Inc.

Today 07:01 pm	BORA PHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-12-04 02:06 am	CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-11-28	DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release
2024-11-15 01:38 am	BAVARIAN NORDIC A/S: Q3 2024 Earnings Release
2024-11-14 11:01 pm	CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release
2024-11-14 09:03 am	GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release
2024-11-14 07:00 am	OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release
2024-11-14 02:49 am	IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release
2024-11-14 01:30 am	DERMAPHARM HOLDING SE: Q3 2024 Earnings Release
2024-11-14 01:30 am	ALK-ABELLÓ A/S: Q3 2024 Earnings Release